PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Narcan 400micrograms/1ml solution for injection ampoules
1902070Q0BBAAAA
Narcan Naloxone hydrochloride Other Drugs and Preparations No data available
Narcan Neonatal 40micrograms/2ml inj ampoules
1501070G0BBAAAA
Narcan Neonatal Naloxone hydrochloride Anaesthesia No data available
Naropin 100mg/10ml solution for injection ampoules
1502010R0BBADAE
Naropin Ropivacaine hydrochloride Anaesthesia No data available
Naropin 200mg/100ml infusion Polybags
1502010R0BBAEAF
Naropin Ropivacaine hydrochloride Anaesthesia No data available
Naropin 20mg/10ml solution for injection ampoules
1502010R0BBAAAA
Naropin Ropivacaine hydrochloride Anaesthesia No data available
Naropin 400mg/200ml infusion Polybags
1502010R0BBACAD
Naropin Ropivacaine hydrochloride Anaesthesia No data available
Naropin 75mg/10ml solution for injection ampoules
1502010R0BBABAB
Naropin Ropivacaine hydrochloride Anaesthesia No data available
Narrow ostomy belt 102cm
23302403020
Narrow ostomy belt 102cm Belts Stoma Appliances No data available
Narrow ostomy belt 97cm
23302403019
Narrow ostomy belt 97cm Belts Stoma Appliances No data available
Nasciodine medicated massage cream
1003020N0BKAAA0
Nasciodine Methyl salicylate Musculoskeletal and Joint Diseases No data available
Nastrosa 1mg tablets
0803041B0BCAAAA
Nastrosa Anastrozole Malignant Disease and Immunosuppression No data available
Natacyn 5% ophthalmic suspension
1103010P0BBAAAA
Natacyn Natamycin Eye No data available
Natalizumab 300mg/15ml solution for infusion vials
0802040W0AAAAAA
Natalizumab Natalizumab Malignant Disease and Immunosuppression No data available
Natamycin 5% eye drops
1103010P0AAAAAA
Natamycin (Eye) Natamycin Eye No data available
National 30 day HIV post exposure prophylaxis pack
0503010AYBBAAAA
National 30 day HIV Raltegravir/Emtricitabine/Tenofovir disoproxil Infections No data available
Natracalm 71.4mg tablets
091200000BBMUA0
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Natragen Glucosamine 400mg / Chondroitin 100mg capsules
091200000BFNAEE
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Natragen Glucosamine 500mg / Chondroitin 400mg capsules
091200000BFQSEF
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Natragen Glucosamine 500mg / Chondroitin 400mg tablets
091200000BFMZEC
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Natragen Glucosamine sulfate 1500mg tablets
091200000BFMXDW
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Natragen Sodium bicarbonate 500mg capsules
0902013S0BBAAAC
Natragen sodium bicarbonate (Supplements) Sodium bicarbonate Nutrition and Blood No data available
Natragen Sodium bicarbonate 600mg tablets
0902013S0BBABAP
Natragen sodium bicarbonate (Supplements) Sodium bicarbonate Nutrition and Blood No data available
NatraHealth Glucosamine 400mg / Chondroitin 100mg capsules
091200000BETEEE
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
NatraHealth Glucosamine 500mg / Chondroitin 400mg tablets
091200000BFMYEC
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
NatraHealth Glucosamine sulfate 1500mg tablets
091200000BFMWDW
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.